These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

153 related items for PubMed ID: 37827967

  • 21. P. falciparum and P. vivax Epitope-Focused VLPs Elicit Sterile Immunity to Blood Stage Infections.
    Whitacre DC, Espinosa DA, Peters CJ, Jones JE, Tucker AE, Peterson DL, Zavala FP, Milich DR.
    PLoS One; 2015; 10(5):e0124856. PubMed ID: 25933001
    [Abstract] [Full Text] [Related]

  • 22. RTS,S/AS01 malaria vaccine mismatch observed among Plasmodium falciparum isolates from southern and central Africa and globally.
    Pringle JC, Carpi G, Almagro-Garcia J, Zhu SJ, Kobayashi T, Mulenga M, Bobanga T, Chaponda M, Moss WJ, Norris DE.
    Sci Rep; 2018 Apr 26; 8(1):6622. PubMed ID: 29700348
    [Abstract] [Full Text] [Related]

  • 23. Development of a self-assembling protein nanoparticle vaccine targeting Plasmodium falciparum Circumsporozoite Protein delivered in three Army Liposome Formulation adjuvants.
    Seth L, Bingham Ferlez KM, Kaba SA, Musser DM, Emadi S, Matyas GR, Beck Z, Alving CR, Burkhard P, Lanar DE.
    Vaccine; 2017 Oct 04; 35(41):5448-5454. PubMed ID: 28274638
    [Abstract] [Full Text] [Related]

  • 24. Multiple antigen peptide vaccines against Plasmodium falciparum malaria.
    Mahajan B, Berzofsky JA, Boykins RA, Majam V, Zheng H, Chattopadhyay R, de la Vega P, Moch JK, Haynes JD, Belyakov IM, Nakhasi HL, Kumar S.
    Infect Immun; 2010 Nov 04; 78(11):4613-24. PubMed ID: 20823210
    [Abstract] [Full Text] [Related]

  • 25. IgG2 antibodies against a clinical grade Plasmodium falciparum CSP vaccine antigen associate with protection against transgenic sporozoite challenge in mice.
    Schwenk R, DeBot M, Porter M, Nikki J, Rein L, Spaccapelo R, Crisanti A, Wightman PD, Ockenhouse CF, Dutta S.
    PLoS One; 2014 Nov 04; 9(10):e111020. PubMed ID: 25343487
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Plasmodium falciparum synthetic LbL microparticle vaccine elicits protective neutralizing antibody and parasite-specific cellular immune responses.
    Powell TJ, Tang J, Derome ME, Mitchell RA, Jacobs A, Deng Y, Palath N, Cardenas E, Boyd JG, Nardin E.
    Vaccine; 2013 Apr 08; 31(15):1898-904. PubMed ID: 23481177
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Combination of protein and viral vaccines induces potent cellular and humoral immune responses and enhanced protection from murine malaria challenge.
    Hutchings CL, Birkett AJ, Moore AC, Hill AV.
    Infect Immun; 2007 Dec 08; 75(12):5819-26. PubMed ID: 17908809
    [Abstract] [Full Text] [Related]

  • 31. Importance of the Immunodominant CD8+ T Cell Epitope of Plasmodium berghei Circumsporozoite Protein in Parasite- and Vaccine-Induced Protection.
    Gibbins MP, Müller K, Glover M, Liu J, Putrianti ED, Bauza K, Reyes-Sandoval A, Matuschewski K, Silvie O, Hafalla JCR.
    Infect Immun; 2020 Sep 18; 88(10):. PubMed ID: 32719159
    [Abstract] [Full Text] [Related]

  • 32. A high-affinity antibody against the CSP N-terminal domain lacks Plasmodium falciparum inhibitory activity.
    Thai E, Costa G, Weyrich A, Murugan R, Oyen D, Flores-Garcia Y, Prieto K, Bosch A, Valleriani A, Wu NC, Pholcharee T, Scally SW, Wilson IA, Wardemann H, Julien JP, Levashina EA.
    J Exp Med; 2020 Nov 02; 217(11):. PubMed ID: 32790871
    [Abstract] [Full Text] [Related]

  • 33. A highly infectious Plasmodium yoelii parasite, bearing Plasmodium falciparum circumsporozoite protein.
    Zhang M, Kaneko I, Tsao T, Mitchell R, Nardin EH, Iwanaga S, Yuda M, Tsuji M.
    Malar J; 2016 Apr 12; 15():201. PubMed ID: 27068454
    [Abstract] [Full Text] [Related]

  • 34. Irradiated sporozoite vaccination induces sex-specific immune responses and protection against malaria in mice.
    Vom Steeg LG, Flores-Garcia Y, Zavala F, Klein SL.
    Vaccine; 2019 Jul 26; 37(32):4468-4476. PubMed ID: 31262583
    [Abstract] [Full Text] [Related]

  • 35. T cell responses to repeat and non-repeat regions of the circumsporozoite protein detected in volunteers immunized with Plasmodium falciparum sporozoites.
    Nardin E, Munesinghe YD, Moreno A, Clavijo P, Calle MC, Edelman R, Davis J, Herrington D, Nussenzweig RS.
    Mem Inst Oswaldo Cruz; 1992 Jul 26; 87 Suppl 3():223-7. PubMed ID: 1364202
    [Abstract] [Full Text] [Related]

  • 36. Linear and multiple antigen peptides containing defined T and B epitopes of the Plasmodium yoelii circumsporozoite protein: antibody-mediated protection and boosting by sporozoite infection.
    Marussig M, Rénia L, Motard A, Miltgen F, Pétour P, Chauhan V, Corradin G, Mazier D.
    Int Immunol; 1997 Dec 26; 9(12):1817-24. PubMed ID: 9466309
    [Abstract] [Full Text] [Related]

  • 37. In vitro expression and in vivo immunogenicity of Plasmodium falciparum pre-erythrocytic stage DNA vaccines.
    Hedstrom RC, Doolan DL, Wang R, Kumar A, Sacci JB, Gardner MJ, Aguiar JC, Charoenvit Y, Sedegah M, Tine JA, Margalith M, Hobart P, Hoffman SL.
    Int J Mol Med; 1998 Jul 26; 2(1):29-38. PubMed ID: 9854139
    [Abstract] [Full Text] [Related]

  • 38. Clinical trial in healthy malaria-naïve adults to evaluate the safety, tolerability, immunogenicity and efficacy of MuStDO5, a five-gene, sporozoite/hepatic stage Plasmodium falciparum DNA vaccine combined with escalating dose human GM-CSF DNA.
    Richie TL, Charoenvit Y, Wang R, Epstein JE, Hedstrom RC, Kumar S, Luke TC, Freilich DA, Aguiar JC, Sacci JB, Sedegah M, Nosek RA, De La Vega P, Berzins MP, Majam VF, Abot EN, Ganeshan H, Richie NO, Banania JG, Baraceros MF, Geter TG, Mere R, Bebris L, Limbach K, Hickey BW, Lanar DE, Ng J, Shi M, Hobart PM, Norman JA, Soisson LA, Hollingdale MR, Rogers WO, Doolan DL, Hoffman SL.
    Hum Vaccin Immunother; 2012 Nov 01; 8(11):1564-84. PubMed ID: 23151451
    [Abstract] [Full Text] [Related]

  • 39. Adenovirus particles that display the Plasmodium falciparum circumsporozoite protein NANP repeat induce sporozoite-neutralizing antibodies in mice.
    Palma C, Overstreet MG, Guedon JM, Hoiczyk E, Ward C, Karen KA, Zavala F, Ketner G.
    Vaccine; 2011 Feb 11; 29(8):1683-9. PubMed ID: 21199707
    [Abstract] [Full Text] [Related]

  • 40. Assessment of the Plasmodium falciparum Preerythrocytic Antigen UIS3 as a Potential Candidate for a Malaria Vaccine.
    Longley RJ, Halbroth BR, Salman AM, Ewer KJ, Hodgson SH, Janse CJ, Khan SM, Hill AVS, Spencer AJ.
    Infect Immun; 2017 Mar 11; 85(3):. PubMed ID: 28031267
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.